Effects of alprostadil combined with calcium dobesilate in patients with diabetic peripheral neuropathy.
CONCLUSION: Combined alprostadil and calcium dobesilate treatment for type 2 diabetic peripheral neuropathy showed good clinical efficacy and an improved curative effect than single alprostadil treatment.
PMID: 30183208 [PubMed - as supplied by publisher]
Source: Neuroendocrinology Letters - Category: Endocrinology Tags: Neuro Endocrinol Lett Source Type: research
More News: Brain | Calcium | Diabetes | Diabetes Type 2 | Endocrinology | Neurology | Peripheral Neuropathy